Neuroblastoma breakpoint family, member 4 pseudogene

The neuroblastoma breakpoint family, member 4 pseudogene is a **pseudogene** in humans (Homo sapiens), identified by Ensembl gene ID ENSG00000224335[1][3]. Pseudogenes are nonfunctional genomic DNA segments that closely resemble functional genes, but are generally unable to code for functional proteins due to disabling mutations or regulatory sequence loss[4]. While some pseudogenes may be transcribed and have regulatory functions (such as acting as microRNA decoys or influencing gene expression), most do not encode active proteins and are considered non-coding[2][4][6]. The NBPF (neuroblastoma breakpoint family) family, to which this pseudogene is related, includes genes and pseudogenes exhibiting structural variation and tandem repeats (e.g., DUF1220 protein domains), some of which have been linked to neurodevelopmental disorders and cancer[5][7]. However, this particular pseudogene, Neuroblastoma breakpoint family, member 4 pseudogene (NBPF4 pseudogene), does not have a known protein product nor clear evidence as a therapeutic target or disease biomarker. **Key points:** - This entry is not a true drug target (not a receptor, enzyme, transporter, etc.), but a pseudogene. - There may be some confusion because NBPF family genes (but not pseudogenes) can play roles in diseases such as neuroblastoma and various cancers, but this pseudogene itself lacks such associations[1][5][7]. - No drugs interact with this pseudogene, nor does it have a mechanism of action, safety concerns, or biomarker utility as established from current evidence. If you are searching for a potential therapeutic target or biomarker, you should consider canonical NBPF family genes, not pseudogenes.

Other names

AC239809.1NBPF4 pseudogene